Retraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically (Molecular Therapy (2016) 24(2) (261–275), (S152500161630332X), (10.1038/mt.2015.208));SET1A cooperates with CUDR to promote liver cancer growth and hepatocyte-like stem cell malignant transformation epigenetically

Molecular Therapy

Volumn 24, Issue 2, 2016, Pages 261-275

  Li, Tianming ^a   Zheng, Qidi ^a   An, Jiahui ^a   Wu, Mengying ^a   Li, Haiyan ^a   Gui, Xin ^a   Pu, Hu ^a   Lu, Dongdong ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; LONG UNTRANSLATED RNA; MYC PROTEIN; PROTEIN RB1; PROTEIN SET1A; RETINOBLASTOMA PROTEIN; RNA CUDR; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG; HISTONE LYSINE METHYLTRANSFERASE; SETD1A PROTEIN, HUMAN; UCA1 RNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STEM CELL; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; EPIGENETICS; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TELOMERE HOMEOSTASIS; ANIMAL; CELL TRANSFORMATION; GENETIC EPIGENESIS; GENETICS; HEP-G2 CELL LINE; LIVER TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; STEM CELL; UPREGULATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; HEP G2 CELLS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LIVER NEOPLASMS; MICE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RETINOBLASTOMA PROTEIN; RNA, LONG NONCODING; STEM CELLS; UP-REGULATION;

EID: 84959550679     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1016/j.ymthe.2023.03.016     Document Type: Erratum

References (60)

1. Duncan, SA and Watt, AJ (2001). BMPs on the road to hepatogenesis. Genes Dev 15: 1879-1884.
2. Zaret, KS (2000). Liver specification and early morphogenesis. Mech Dev 92: 83-88.
3. Kubota, H and Reid, LM (2000). Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc Natl Acad Sci USA 97: 12132-12137.
4. Tanimizu, N, Nishikawa, M, Saito, H, Tsujimura, T and Miyajima, A (2003). Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 116: 1775-1786.
5. Parviz, F, Matullo, C, Garrison, WD, Savatski, L, Adamson, JW, Ning, G, et al. (2003). Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34: 292-296.
6. Coffinier, C, Gresh, L, Fiette, L, Tronche, F, Schütz, G, Babinet, C, et al. (2002). Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development 129: 1829-1838.
7. Clotman, F, Lannoy, VJ, Reber, M, Cereghini, S, Cassiman, D, Jacquemin, P, et al. (2002). The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 129: 1819-1828.
8. Pontoglio, M, Barra, J, Hadchouel, M, Doyen, A, Kress, C, Bach, JP, et al. (1996). Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria and renal Fanconi syndrome. Cell 84: 575-585.
9. Shi X, Sun M, Liu H, Yao Y, Song Y (2013). Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 339: 159-166.
10. Zhou, Q, Huang, XR, Yu, J, Yu, X and Lan, HY (2015). Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation. Mol Ther 23: 1034-1043.
11. Saayman, S, Ackley, A, Turner, AM, Famiglietti, M, Bosque, A, Clemson, M, et al. (2014). An HIV-Encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol Ther 22: 1164-1175.
12. Wong, HK, Fatimy, RE, Onodera, C, Wei, Z, Yi, M, Mohan, A, et al. (2015). The cancer genome atlas analysis predicts microRNA for targeting cancer growth and vascularization in glioblastoma. Mol Ther 23: 1234-1247.
13. Li, H, Yu, B, Li, J, Su, L, Yan, M, Zhu, Z, et al. (2014). Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 5: 2318-2329.
14. Tsang, WP, Wong, TW, Cheung, AH, Co, CN and Kwok, TT (2007). Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA 13: 890-898.
15. Han, Y, Yang, YN, Yuan, HH, Zhang, TT, Sui, H, Wei, XL, et al. (2014). UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology 46: 396-401.
16. Li, Z, Li, X, Wu, S, Xue, M and Chen, W (2014). Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/ microRNA143 pathway. Cancer Sci 105: 951-955.
17. Xue, M, Li, X, Li, Z and Chen, W (2014). Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1?β-Targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration and invasion. Tumour Biol 35: 6901-6912.
18. Kumar, P, Emechebe, U, Smith, R, Franklin, S, Moore, B, Yandell, M, et al. (2014). Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. Elife 3: e02805.
19. Fan, Y, Shen, B, Tan, M, Mu, X, Qin, Y, Zhang, F, et al. (2014). Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 281: 1750-1758.
20. Liu, SP, Yang, JX, Cao, DY and Shen, K (2013). Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med 10: 138-141.
21. Fang, Z, Wu, L, Wang, L, Yang, Y, Meng, Y and Yang, H (2014). Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 117: 89-95.
22. Jiang, M, Huang, O, Xie, Z, Wu, S, Zhang, X, Shen, A, et al. (2014). A novel long noncoding RNA-ARA: adriamycin resistance-Associated. Biochem Pharmacol 87: 254-283.
23. Wang, Y, Chen, W, Yang, C, Wu, W, Wu, S, Qin, X, et al. (2012). Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol 41: 276-284.
24. Wang, F, Li, X, Xie, X, Zhao, L and Chen, W (2008). UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 582: 1919-1927.
25. Schneider, R, Bannister, AJ and Kouzarides, T (2002). Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 27: 396-402.
26. Shinsky, SA, Monteith, KE, Viggiano, S and Cosgrove, MS (2015). Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation. J Biol Chem 290: 6361-6375.
27. Nguyen, P, Bar-Sela, G, Sun, L, Bisht, KS, Cui, H, Kohn, E, et al. (2008). BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression. Mol Cell Biol 28: 6720-6729.
28. Mikheyeva, IV, Grady, PJ, Tamburini, FB, Lorenz, DR and Cam, HP (2014). Multifaceted genome control by Set1 dependent and independent of H3K4 methylation and the Set1C/COMPASS complex. PLoS Genet 10: e1004740.
29. Lorenz, DR, Meyer, LF, Grady, PJ, Meyer, MM and Cam, HP (2014). Heterochromatin assembly and transcriptome repression by Set1 in coordination with a class II histone deacetylase. Elife 3: e04506.
30. South, PF, Harmeyer, KM, Serratore, ND and Briggs, SD (2013). H3K4 methyltransferase Set1 is involved in maintenance of ergosterol homeostasis and resistance to Brefeldin A. Proc Natl Acad Sci USA 110: E1016-E1025.
31. Benayoun, BA, Pollina, EA, Ucar, D, Mahmoudi, S, Karra, K, Wong, ED, et al. (2014). H3K4me3 breadth is linked to cell identity and transcriptional consistency. Cell 158: 673-688.
32. Benard, A, Goossens-Beumer, IJ, van Hoesel, AQ, de Graaf, W, Horati, H, Putter, H, et al. (2014). Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer. BMC Cancer 14: 531.
33. Wong, SH, Goode, DL, Iwasaki, M, Wei, MC, Kuo, HP, Zhu, L, et al. (2015). The H3K4-methyl epigenome regulates leukemia stem cell oncogenic potential. Cancer Cell 28: 198-209.
34. Jiang, H, Shukla, A, Wang, X, Chen, WY, Bernstein, BE and Roeder, RG (2011). Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell 144: 513-525.
35. Indovina, P, Pentimalli, F, Casini, N, Vocca, I and Giordano, A (2015). RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy. Oncotarget 6: 17873-17890.
36. Xu, XL, Singh, HP, Wang, L, Qi, DL, Poulos, BK, Abramson, DH, et al. (2014). Rb suppresses human cone-precursor-Derived retinoblastoma tumours. Nature 514: 385-388.
37. Ma, W, Yu, J, Qi, X, Liang, L, Zhang, Y, Ding, Y, et al. (2015). Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb. Oncotarget 6: 15984-15994.
38. Shen, F, Mo, MH, Chen, L, An, S, Tan, X, Fu, Y, et al. (2014). MicroRNA-21 downregulates Rb1 expression by targeting PDCD4 in retinoblastoma. J Cancer 5: 804-812.
39. Hagen, J, Muniz, VP, Falls, KC, Reed, SM, Taghiyev, AF, Quelle, FW, et al. (2014). RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-Dependent manner. Cancer Res 74: 6661-6670.
40. Martínez, P, Ferrara-Romeo, I, Flores, JM and Blasco, MA (2014). Essential role for the TRF2 telomere protein in adult skin homeostasis. Aging Cell 13: 656-668.
41. Her, YR and Chung, IK (2013). p300-mediated acetylation of TRF2 is required for maintaining functional telomeres. Nucleic Acids Res 41: 2267-2283.
42. Bojovic, B, Ho, HY, Wu, J and Crowe, DL (2013). Stem cell expansion during carcinogenesis in stem cell-Depleted conditional telomeric repeat factor 2 null mutant mice. Oncogene 32: 5156-5166.
43. Sarek, G, Vannier, JB, Panier, S, Petrini, JH and Boulton, SJ (2015). TRF2 recruits RTEL1 to telomeres in S phase to promote t-loop unwinding. Mol Cell 57: 622-635.
44. Pitman, RT, Wojdyla, L and Puri, N (2013). Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma. Oncotarget 4: 761-771.
45. Kaneko, K, Ito, Y, Ono, Y, Tainaka, T, Tsuchiya, H, Shimoyama, Y, et al. (2011). Gene expression profiling reveals upregulated UCA1 and BMF in gallbladder epithelia of children with pancreaticobiliary maljunction. J Pediatr Gastroenterol Nutr 52: 744-750.
46. Wang, XS, Zhang, Z, Wang, HC, Cai, JL, Xu, QW, Li, MQ, et al. (2006). Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12: 4851-4858.
47. Wu, W, Zhang, S, Li, X, Xue, M, Cao, S and Chen, W (2013). Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One 8: e73920.
48. Yang, Z, Augustin, J, Chang, C, Hu, J, Shah, K, Chang, CW, et al. (2014). The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells. Blood 124: 2025-2033.
49. Zhang, K, Lin, W, Latham, JA, Riefler, GM, Schumacher, JM, Chan, C, et al. (2005). The Set1 methyltransferase opposes Ipl1 aurora kinase functions in chromosome segregation. Cell 122: 723-734.
50. Yokoyama, A, Wang, Z, Wysocka, J, Sanyal, M, Aufiero, DJ, Kitabayashi, I, et al. (2004). Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24: 5639-5649.
51. Kim, DH, Tang, Z, Shimada, M, Fierz, B, Houck-Loomis, B, Bar-Dagen, M, et al. (2013). Histone H3K27 trimethylation inhibits H3 binding and function of SET1-like H3K4 methyltransferase complexes. Mol Cell Biol 33: 4936-4946.
52. Tang, Z, Chen, WY, Shimada, M, Nguyen, UT, Kim, J, Sun, XJ, et al. (2013). SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell 154: 297-310.
53. Lin, B, Lee, H, Yoon, JG, Madan, A, Wayner, E, Tonning, S, et al. (2015). Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene. Oncotarget 6: 5369-5381.
54. Rondinelli, B, Schwerer, H, Antonini, E, Gaviraghi, M, Lupi, A, Frenquelli, M, et al. (2015). H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing. Nucleic Acids Res 43: 2560-2574.
55. Poulet, A, Pisano, S, Faivre-Moskalenko, C, Pei, B, Tauran, Y, Haftek-Terreau, Z, et al. (2012). The N-Terminal domains of TRF1 and TRF2 regulate their ability to condense telomeric DNA. Nucleic Acids Res 40: 2566-2576.
56. Wood, AM, Rendtlew Danielsen, JM, Lucas, CA, Rice, EL, Scalzo, D, Shimi, T, et al. (2014). TRF2 and lamin A/C interact to facilitate the functional organization of chromosome ends. Nat Commun 5: 5467.
57. Porro, A, Feuerhahn, S and Lingner, J (2014). TERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeres. Cell Rep 6: 765-776.
58. Doksani, Y, Wu, JY, de Lange, T and Zhuang, X (2013). Super-resolution fluorescence imaging of telomeres reveals TRF2-Dependent T-loop formation. Cell 155: 345-356.
59. Porro, A, Feuerhahn, S, Delafontaine, J, Riethman, H, Rougemont, J and Lingner, J (2014). Functional characterization of the TERRA transcriptome at damaged telomeres. Nat Commun 5: 5379.
60. Shiraki, N, Umeda, K, Sakashita, N, Takeya, M, Kume, K and Kume, S (2008). Differentiation of mouse and human embryonic stem cells into hepatic lineages. Genes Cells 13: 731-746.